Merck KGaA, Darmstadt, Germany
↗Darmstadt, Germany
Merck KGaA is a leading science and technology company operating across healthcare, life science, and electronics. Founded in 1668, it is the world's oldest operating chemical and pharmaceutical company. In the United States and Canada, the company operates as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Biotechnology and Life Sciences
SIZE & FINANCIALS
Employees:10000+
Revenue:$21B-$23B
Founded:1668
Ownership:public
Status:operating
FUNDING
Stage:Pre-IPO
Investors:E. Merck KG (70.3% majority owner), Free float (29.7%)
STOCK
Exchange:XETRA
Ticker:MRK
Market Cap:$75.4B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, mAb, ADC, Recombinant proteins
Active Trials:85
Trial Phases:Phase 1: 28 | Phase 2: 32 | Phase 3: 20 | Phase 4: 5
FDA Approvals:12
EMA Approvals:15
CORPORATE STRUCTURE
Subsidiaries:EMD Serono, MilliporeSigma, EMD Electronics, Versum Materials
Key Partnerships:Pfizer (Bavencio co-development), GSK (Bintrafusp alfa - terminated), Bayer (Cardiovascular research)
COMPETITION
Position:Leader
Competitors:Bayer, Sanofi, Roche, Novartis, Thermo Fisher Scientific
LEADERSHIP
Key Executives:
Belén Garijo - CEO and Chair of the Executive Board
Helene von Roeder - CFO
Scientific Founders:Friedrich Jacob Merck
Board Members:Wolfgang Büchele, Michael Kleinemeier
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Merck KGaA, Darmstadt, Germany. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.